Tuesday, June 11, 2013 10:17:58 AM
press release
June 10, 2013, 12:04 p.m. EDT
Greyson International Provides an Update on its Operations
COCONUT CREEK, Fla., Jun 10, 2013 (BUSINESS WIRE) -- Greyson International Inc. (otc pink:GYSN), developer of an innovative, patented topical delivery technology targeting the multi-billion dollar cosmetics and OTC pharmaceutical industries, today announced the sale of a portion of its interest in Blake Oil & Gas Limited ("Blake"), a privately owned, Guernsey registered oil and Gas Company with operations in the country of Georgia. The proceeds of approximately $1 million will be used to aggressively pursue retail distribution deals for its breakthrough Trilexon(R) powered products, as well as market Greyson Bio medical's technology to potential licensees in the pharmaceutical industry.
Covered by U.S. Patent 8,268,335, Greyson International's Trilexon(R) technology combines a cationic emulsifying agent, oil soluble liquid polymer and natural occurring lactate buffer system to dramatically improve the topical delivery of active ingredients in both the cosmetics and pharmaceutical industries.
"The sale of a portion of our interest in Blake provides us with the funding necessary to unlock the enormous potential in our breakthrough Trilexon(R) delivery technology across multiple end markets," said Greyson International Inc. CEO Harvey Tauman. "We believe that Trilexon(R) will play a vital role in both the hypercompetitive cosmetics industry, where companies are always looking for a competitive edge, and the pharmaceutical industry where the larger players are facing so-called patent cliffs, and are looking for new ways to extend patent lives."
Management will provide additional details about these programs as they are implemented over the coming months.
About Greyson International, Inc.
Greyson's primary focus is on its recently patented Trilexon(R) delivery system. In addition to cosmetic applications, Trilexon(R) may also have benefits in the medical field where it is important to deliver active ingredients. Trilexon(R) is a registered trademark of Greyson International Inc. For more information, visit our website; http://greysonintl.com and join the Greyson International's Facebook page http://www.facebook.com/GreysonInternationalInc.
This release contains information about management's view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.
http://cts.businesswire.com/ct/CT?id=bwnews&sty=20130610006165r1&sid=cmtx6&distro=nx
SOURCE: Greyson International Inc.
Disclaimer; It's mostly opinion.
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM